Patent application number | Description | Published |
20130107932 | Receiver and Method for Detecting a Pre-Coded Signal | 05-02-2013 |
20130208766 | Data Detection and Receiver Circuit - A method includes a first step of receiving a signal at a first receiver circuit on the basis of a mobile communications standard supporting multiple predefined modulation alphabets wherein the received signal includes first data dedicated to the first receiver circuit and second data dedicated to a second, different receiver circuit, a second step of determining a modulation alphabet of the multiple predefined modulation alphabets during an operation of the first receiver circuit and a third step of detecting data depending on the second data at the first receiver circuit on the basis of the determined modulation alphabet. | 08-15-2013 |
20130208835 | Receiver Circuit and Method for Detecting Data - A method includes a first step of receiving a signal on the basis of a mobile communications standard supporting multiple predefined modulation alphabets and a second step of detecting data of the received signal on the basis of a modulation alphabet which includes modulation symbols of at least two of the multiple predefined modulation alphabets. | 08-15-2013 |
20130279425 | Radio Communications System and Method Performed Therein - A method includes a step of determining a first spatial correlation matrix at a first mobile station, a step of normalizing the first spatial correlation matrix, a step of transmitting the normalized first spatial correlation matrix from the first mobile station to a base station and a step of determining a first channel quality indicator at the base station wherein the first channel quality indicator is based on the normalized first spatial correlation matrix. | 10-24-2013 |
20130301751 | Apparatus and Method for Determining a Precoding Matrix - An apparatus for determining a target precoding matrix from a plurality of precoding matrix candidates is provided. The apparatus includes a covariance matrix value provider, a real part determiner and a precoding matrix determiner. The precoding matrix determiner is adapted to determine the target precoding matrix from the plurality of precoding matrix candidates, wherein the precoding matrix determiner is configured to determine the target precoding matrix based on at least one of the one or more real covariance values. | 11-14-2013 |
20130301756 | Apparatus and Method for Decoding a Received Signal - An apparatus for decoding a received signal is provided. The received signal has been transmitted by conducting a transmission. The apparatus for decoding includes a detector and a filter application unit. The detector is configured to detect whether the transmission is a SU-MIMO transmission or a MU-MIMO transmission. The filter application unit is configured to apply either a first receive filter or a second different receive filter on the received signal depending on whether the transmission is the SU-MIMO transmission or the MU-MIMO transmission. | 11-14-2013 |
20140029659 | PROCESSING DATA IN A RECEIVER CIRCUIT AND RECEIVER CIRCUIT - A method includes receiving a signal including first data precoded on the basis of a first codebook entry of a codebook, wherein the codebook includes at least one further codebook entry, averaging a set of matrices to obtain a mean matrix wherein each matrix of the set of matrices is determined on the basis of a respective other codebook entry of the at least one further codebook entry and determining a covariance matrix on the basis of the mean matrix. | 01-30-2014 |
20140086296 | Receiver with Multi Layer Interference Cancellation - A multi user receiver configured to receive a signal including multiple symbol streams assigned to various users is described. The multiple symbol streams include at least one first symbol stream assigned to a user of the multi user receiver and at least one second symbol stream assigned to another user, wherein a modulation alphabet applied for the at least one second symbol stream is unknown at the multi user receiver. The multi user receiver includes a symbol stream election unit configured to elect a symbol stream of the multiple symbol streams, an equalizer configured to provide an equalized symbol of the elected symbol stream, and a detector configured to generate a detected symbol from the equalized symbol on the basis of a constellation, wherein, if the second symbol stream is elected, the constellation is a mixed constellation including constellation points of at least two of multiple predefined modulation alphabets. | 03-27-2014 |
20140105102 | Method for Determining Feedback Information and Circuit to Perform such Method - A method includes receiving a first signal at a circuit from a first base station and receiving a second signal at the circuit from a second base station different from the first base station. The method further includes determining a first channel estimate based on the first signal, determining a second channel estimate based on the second signal and determining a feedback information based on the first channel estimate and based on the second channel estimate. | 04-17-2014 |
20140113675 | Method and Device for Controlling a Transmit Power in a User Equipment - A device includes a first adjustment unit which is configured to adjust a power of a first carrier signal, and a second adjustment unit configured to adjust a power of a second carrier signal. The first adjustment unit is configured to adjust the first carrier signal power based on a maximum allowable imbalance between the first carrier signal power and the second carrier signal power. A method for controlling a transmit power in a user equipment of a radio communications system includes calculating in the user equipment first carrier signal power and a second carrier signal power. The method further includes adjusting in the user equipment the calculated transmit power for at least one out of the first carrier signal and the second carrier signal based on the maximum allowable power imbalance between the first carrier signal power and the second carrier signal power. | 04-24-2014 |
20140119278 | Methods and Circuits for Determining Feedback Information - A method includes receiving at a circuit an information on a partitioned time interval wherein the partitioned time interval includes a first time element and a second, different time element. The method further includes determining a single-cell feedback information based on first data wherein the first data is received by the circuit during the first time element. The method further includes determining a multi-cell feedback information based on second data wherein the second data is received by the circuit during the second time element. | 05-01-2014 |
20140161157 | Interference and Noise Estimation in a Multiple Input Multiple Output (MIMO) Receiver - A receiver circuit receives a signal including a first reference signal from a first antenna port that is allocated to the UE. The receiver circuit includes a descrambling and despreading unit that despreads and descrambles the signal using a spreading code of the first antenna port and a scrambling sequence assigned to the UE to generate a first antenna port signal. The descrambling and despreading unit despreads and descrambles the signal using a spreading code of a second antenna port and the scrambling sequence assigned to the UE, wherein the second antenna port is unallocated to the UE to generate a second antenna port signal. A channel estimator generates a channel estimate of the first antenna port based on the first antenna port signal. An estimation unit estimates an interference and noise covariance measure based on the first antenna port signal, the channel estimate and the second antenna port signal. | 06-12-2014 |
Patent application number | Description | Published |
20090163564 | Translational Dysfunction Based Therapeutics - Provided are methods and compositions for inhibiting eukaryotic translation initiation factor eIF4E. Such methods and compositions may be used alone or in conjunction with other therapies, such as gene therapies, for inhibiting cell proliferation and/or treating cancer. | 06-25-2009 |
20130209578 | Combinatory Cancer Treatment - The present invention relates to a pharmaceutical composition for treating a neoplasm, a preneoplasm, a proliferative disorder and/or a precancerous lesion, the use of such compositions for the treatment of the listed conditions, and methods of treating the listed conditions. The composition of the present invention comprises an inhibitor of eIF4E, a methltransferase inhibitor, and a pharmaceutically acceptable carrier. | 08-15-2013 |
20140199692 | TRANSLATIONAL DYSFUNCTION BASED THERAPEUTICS - Provided are methods and compositions for inhibiting eukaryotic translation initiation factor eIF4E. Such methods and compositions may be used alone or in conjunction with other therapies, such as gene therapies, for inhibiting cell proliferation and/or treating cancer. | 07-17-2014 |
Patent application number | Description | Published |
20110293755 | STABILIZED FORMULATION COMPRISING OMEGA-3 FATTY ACIDS AND USE OF THE FATTY ACIDS FOR SKIN CARE AND/OR WOUND CARE - A stabilized formulation for skin care, wound care and/or other tissue healing applications and methods for making the same is described. The stabilized formulation stabilizes omega-3 polyunsaturated fatty acids and is constituted of the omega-3 polyunsaturated fatty acids in combination with tocopherol (Vitamin E), ascorbic acid (Vitamin C), herb extract, and a fat-soluble antioxidant. Methods for making and using the stabilized formulation are also described. | 12-01-2011 |
20140050808 | STABILIZED FORMULATION COMPRISING OMEGA-3 FATTY ACIDS AND USE OF THE FATTY ACIDS FOR SKIN CARE AND/OR WOUND CARE - A stabilized formulation for skin care, wound care and/or other tissue healing applications and methods for making the same is described. The stabilized formulation stabilizes omega-3 polyunsaturated fatty acids and is constituted of the omega-3 polyunsaturated fatty acids in combination with tocopherol (Vitamin E), ascorbic acid (Vitamin C), herb extract, and a fat-soluble antioxidant. Methods for making and using the stabilized formulation are also described. | 02-20-2014 |
20140213649 | STABILIZED FORMULATION COMPRISING OMEGA-3 FATTY ACIDS AND USE OF THE FATTY ACIDS FOR SKIN CARE AND/OR WOUND CARE - A stabilized formulation for skin care, wound care and/or other tissue healing applications and methods for making the same is described. The stabilized formulation stabilizes omega-3 polyunsaturated fatty acids and is constituted of the omega-3 polyunsaturated fatty acids in combination with tocopherol (Vitamin E), ascorbic acid (Vitamin C), herb extract, and a fat-soluble antioxidant. Methods for making and using the stabilized formulation are also described. | 07-31-2014 |
Patent application number | Description | Published |
20090029843 | High-volume, fully dense silicon nitride monolith and method of making by simultaneously joing and hot pressing a plurality of RBSN parts - High-volume, fully dense, multi-component monoliths with microstructurally indistinguishable joints that can be used as refractory, corrosion and wear resistant components in the non-ferrous metal industry. The Si | 01-29-2009 |
20100130344 | High resistivity SiC material with B, N and O as the only additions - A dense silicon carbide (SiC) material with boron (B), nitrogen (N) and oxygen (O) as the only additives and with excellent insulting performance (electrical volume resistivity greater than 1×10 | 05-27-2010 |
20110021031 | HIGH LIFETIME CONSUMABLE SILICON NITRIDE-SILICON DIOXIDE PLASMA PROCESSING COMPONENTS - A method of increasing mean time between cleans of a plasma etch chamber and chamber parts lifetimes is provided. Semiconductor substrates are plasma etched in the chamber while using at least one sintered silicon nitride component exposed to ion bombardment and/or ionized halogen gas. The sintered silicon nitride component includes high purity silicon nitride and a sintering aid consisting of silicon dioxide. A plasma processing chamber is provided including the sintered silicon nitride component. A method of reducing metallic contamination on the surface of a silicon substrate during plasma processing is provided with a plasma processing apparatus including one or more sintered silicon nitride components. A method of manufacturing a component exposed to ion bombardment and/or plasma erosion in a plasma etch chamber, comprising shaping a powder composition consisting of high purity silicon nitride and silicon dioxide and densifying the shaped component. | 01-27-2011 |
20120190530 | Dense Silicon Nitride Body Having High Strength, High Weibull Modulus and high fracture toughness - Silicon nitride materials with high strength, fracture toughness values, and Weibull moduli simultaneously, due to unique large grain reinforcing microstructures and well engineered grain boundary compositions. The invention demonstrates that, surprisingly and contrary to prior art, a silicon nitride material can be made which simultaneously has high strength above about 850-900 MPa, a Weibull above about 15 and high fracture toughness (above about 8 and 9 MPa·m | 07-26-2012 |
20130157836 | Si3N4 insulator material for corona discharge igniter systems - A silicon nitride material is disclosed which has properties necessary for efficient operation of a corona discharge igniter system in an internal combustion gas engine allowing an increase in fuel efficiency of over 10%. The material is disclosed in a range of compositions, all of which exhibit high dielectric strengths, high mechanical strength, thermal shock resistance and fracture toughness, low dielectric constant and loss tangent and electrical resistivity, all of which significantly increase the efficiency of the igniter system over current state of the art alumina insulators. Moreover, the materials retain their dielectric strength and structural integrity at elevated temperatures, up to 800° C.-1000° C. One embodiment comprises a sintered silicon nitride process comprising powder batching, binder removal and sintering. In the preferred embodiment the method of manufacture for silicon nitride is an SRBSN process comprising powder batching, powder pressing, binder removal, nitriding and sintering. | 06-20-2013 |
20140200131 | Si3N4 INSULATOR MATERIAL FOR CORONA DISCHARGE IGNITER SYSTEMS - A silicon nitride material is disclosed which has properties beneficial for efficient operation of a corona discharge igniter system in an internal combustion gas engine. | 07-17-2014 |
Patent application number | Description | Published |
20100120906 | MODIFIED RELEASE FORMULATION AND METHODS OF USE - A modified release pharmaceutical formulation includes about 30-70% N-(2-amino-4-(fluorobenzylamino)-phenyl)carbamic acid ethyl ester (retigabine), or a pharmaceutically acceptable salt, solvate or hydrate thereof, about 5-30% of a drug delivery matrix including hydroxypropylmethylcellulose (HPMC), about 1.0-10% of an anionic surfactant, and an enteric polymer. The pharmaceutical formulation produces a sustained plasma concentration of retigabine following administration to a subject for 4-20 hours longer than the time required for in vitro release of 80% of retigabine. A formulation includes about 30-70% N-(2-amino-4-(fluorobenzylamino)-phenyl)carbamic acid ethyl ester (retigabine), or a pharmaceutically acceptable salt, solvate or hydrate thereof, about 5-30% of a drug delivery matrix, and an agent for retarding release in the gastric environment. The plasma concentration vs. time profile of this formulation is substantially flat over an extended period lasting for about 4 hours to about 36 hours. A method of treating a disorder characterized by nervous system hyperexcitability includes administering to a subject an effective amount of these pharmaceutical formulations. | 05-13-2010 |
20100323015 | MODIFIED RELEASE FORMULATION AND METHODS OF USE - A modified release pharmaceutical formulation includes about 30-70% N-(2-amino-4-(fluorobenzylamino)-phenyl) carbamic acid ethyl ester (retigabine), or a pharmaceutically acceptable salt, solvate or hydrate thereof, about 5-30% of a drug delivery matrix including hydroxypropylmethylcellulose (HPMC), and an enteric polymer. The pharmaceutical formulation produces a sustained plasma concentration of retigabine following administration to a subject for 4-20 hours longer than the time required for in vitro release of 80% of retigabine. The plasma concentration vs. time profile of this formulation is substantially flat over an extended period lasting for about 4 hours to about 36 hours. A method of treating a disorder characterized by nervous system hyperexcitability includes administering to a subject an effective amount of these pharmaceutical formulations. | 12-23-2010 |
20100323016 | MODIFIED RELEASE FORMULATION AND METHODS OF USE - A modified release pharmaceutical formulation includes about 30-70% N-(2-amino-4-(fluorobenzylamino)-phenyl)carbamic acid ethyl ester (retigabine), or a pharmaceutically acceptable salt, solvate or hydrate thereof, about 5-30% of a drug delivery matrix including hydroxypropylmethylcellulose (HPMC), and an enteric polymer. The pharmaceutical formulation produces a sustained plasma concentration of retigabine following administration to a subject for 4-20 hours longer than the time required for in vitro release of 80% of retigabine. The plasma concentration vs. time profile of this formulation is substantially flat over an extended period lasting for about 4 hours to about 36 hours. A method of treating a disorder characterized by nervous system hyperexcitability includes administering to a subject an effective amount of these pharmaceutical formulations. | 12-23-2010 |